Your browser doesn't support javascript.
loading
High clinical and morphologic response using 90Y-DOTA-octreotate sequenced with 177Lu-DOTA-octreotate induction peptide receptor chemoradionuclide therapy (PRCRT) for bulky neuroendocrine tumours.
Kong, Grace; Callahan, Jason; Hofman, Michael S; Pattison, David A; Akhurst, Tim; Michael, Michael; Eu, Peter; Hicks, Rodney J.
Afiliación
  • Kong G; Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. Grace.kong@petermac.org.
  • Callahan J; Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Hofman MS; Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Pattison DA; Department of Medicine, The University of Melbourne, Parkville, Australia.
  • Akhurst T; Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Michael M; Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Eu P; Division of Cancer Medicine, Neuroendocrine Tumour Unit, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Hicks RJ; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.
Eur J Nucl Med Mol Imaging ; 44(3): 476-489, 2017 Mar.
Article en En | MEDLINE | ID: mdl-27678267
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Compuestos Organometálicos / Octreótido / Tumores Neuroendocrinos / Radiofármacos / Quimioradioterapia Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2017 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Compuestos Organometálicos / Octreótido / Tumores Neuroendocrinos / Radiofármacos / Quimioradioterapia Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2017 Tipo del documento: Article País de afiliación: Australia